Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lafiya Biotech is a Nigerian biotechnology company specializing in the development and manufacturing of affordable rapid diagnostic test kits for infectious diseases. The company rose to prominence by providing locally produced COVID-19 testing solutions to improve diagnostic accessibility across Africa. Their product portfolio is designed for point-of-care use, aiming to reduce the continent's dependence on imported medical supplies. Lafiya Biotech continues to expand its diagnostic capabilities to address other endemic diseases such as malaria and HIV. The company leverages lateral flow technology to strengthen healthcare infrastructure and response times in resource-constrained environments. By focusing on local production, they aim to lower costs and improve the speed of disease detection across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lafiya Biotech.